002581 未名医药
已收盘 04-30 15:00:00
资讯
新帖
简况
4月30日未名医药(002581)涨停分析:高校系、新冠防治、疫苗概念驱动
证券之星 · 04-30
4月30日未名医药(002581)涨停分析:高校系、新冠防治、疫苗概念驱动
异动快报:未名医药(002581)4月30日10点5分触及涨停板
证券之星 · 04-30
异动快报:未名医药(002581)4月30日10点5分触及涨停板
未名医药(002581)2025年一季报简析:净利润减33.01%,三费占比上升明显
证券之星 · 04-29
未名医药(002581)2025年一季报简析:净利润减33.01%,三费占比上升明显
未名医药4月29日现2笔大宗交易 成交金额913.52万元
新浪证券-红岸工作室 · 04-29
未名医药4月29日现2笔大宗交易 成交金额913.52万元
A股CRO概念股盘初走低,未名医药一字跌停,双成药业、博济医药、泓博医药、昊帆生物纷纷低开。
美港电讯 · 04-28
A股CRO概念股盘初走低,未名医药一字跌停,双成药业、博济医药、泓博医药、昊帆生物纷纷低开。
六成营收产品被叫停,未名医药触发ST警报,股价火速跌停
格隆汇 · 04-25
六成营收产品被叫停,未名医药触发ST警报,股价火速跌停
异动快报:未名医药(002581)4月25日9点50分触及跌停板
证券之星 · 04-25
异动快报:未名医药(002581)4月25日9点50分触及跌停板
未名医药(002581)2024年年报简析:亏损收窄
证券之星 · 04-24
未名医药(002581)2024年年报简析:亏损收窄
未名医药(002581.SZ)子公司天津未名如三个月内无法恢复生产 则可能触发其他风险警示情形
智通财经 · 04-24
未名医药(002581.SZ)子公司天津未名如三个月内无法恢复生产 则可能触发其他风险警示情形
每周股票复盘:未名医药(002581)大宗交易机构净买入201.82万元
证券之星 · 04-18
每周股票复盘:未名医药(002581)大宗交易机构净买入201.82万元
4月16日未名医药现1笔大宗交易 机构净买入201.82万元
证券之星 · 04-16
4月16日未名医药现1笔大宗交易 机构净买入201.82万元
每周股票复盘:未名医药(002581)大宗交易机构净买入205.09万元
证券之星 · 04-11
每周股票复盘:未名医药(002581)大宗交易机构净买入205.09万元
3月3日未名医药涨停分析:眼科,创新药,新冠病毒防治概念热股
证券之星 · 03-03
3月3日未名医药涨停分析:眼科,创新药,新冠病毒防治概念热股
异动快报:未名医药(002581)3月3日9点49分触及涨停板
证券之星 · 03-03
异动快报:未名医药(002581)3月3日9点49分触及涨停板
未名医药(002581)2月19日主力资金净卖出1634.74万元
证券之星 · 02-20
未名医药(002581)2月19日主力资金净卖出1634.74万元
未名医药(002581.SZ)发预亏,预计2024年度净亏损0.95亿元至1.55亿元
智通财经 · 01-24
未名医药(002581.SZ)发预亏,预计2024年度净亏损0.95亿元至1.55亿元
未名医药:预计2024年全年每股收益亏损:0.144元至0.2349元
证券之星 · 01-24
未名医药:预计2024年全年每股收益亏损:0.144元至0.2349元
【未名医药:签署6463万元工程总承包合同】未名医药公告,公司全资子公司山东衍渡生物科技有限公司将与山东中大工程科技有限公司淄博分公司签署《建设项目工程总承包合同》。合同涉及山东未名生物医药产业园项目的洁净车间及机电总包工程,合同总金额为6463万元,预计工期为180天,计划于2025年2月10日开始施工,并于2025年8月9日完工。合同的执行将有助于公司提高产能规模和市场份额,进一步完善产业布局,增强综合竞争力。
金融界 · 01-23
【未名医药:签署6463万元工程总承包合同】未名医药公告,公司全资子公司山东衍渡生物科技有限公司将与山东中大工程科技有限公司淄博分公司签署《建设项目工程总承包合同》。合同涉及山东未名生物医药产业园项目的洁净车间及机电总包工程,合同总金额为6463万元,预计工期为180天,计划于2025年2月10日开始施工,并于2025年8月9日完工。合同的执行将有助于公司提高产能规模和市场份额,进一步完善产业布局,增强综合竞争力。
未名医药上涨5.13%,报10.86元/股
金融界 · 01-17
未名医药上涨5.13%,报10.86元/股
未名医药收盘下跌2.59%,最新市净率3.44
金融界 · 01-08
未名医药收盘下跌2.59%,最新市净率3.44
加载更多
公司概况
公司名称:
山东未名生物医药股份有限公司
所属行业:
医药制造业
上市日期:
2011-05-20
主营业务:
山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。主要产品有鼠神经生长因子、干扰素、技术服务。公司子公司天津未名是我国率先进入基因工程制药产业化领域的企业之一。重点发展人干扰素α2b系列产品,主要产品捷抚-重组人干扰素α2b喷雾剂(假单胞菌),是全球第一支干扰素喷雾剂。
发行价格:
19.00
{"stockData":{"symbol":"002581","market":"SZ","secType":"STK","nameCN":"未名医药","latestPrice":6.61,"timestamp":1745996580000,"preClose":6.01,"halted":0,"volume":42946976,"delay":0,"changeRate":0.0998,"floatShares":401000000,"shares":660000000,"eps":-0.222,"marketStatus":"已收盘","change":0.6,"latestTime":"04-30 15:00:00","open":5.69,"high":6.61,"low":5.69,"amount":270000000,"amplitude":0.1531,"askPrice":0,"askSize":0,"bidPrice":6.61,"bidSize":7085,"shortable":0,"etf":0,"ttmEps":-0.222,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":6.01,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":6.61,"lowLimit":5.41,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":659735586,"isCdr":false,"pbRate":2.1,"roa":"--","roe":"--","epsLYR":-0.2081,"committee":0,"marketValue":4361000000,"turnoverRate":0.1072,"status":0,"floatMarketCap":2649000000},"requestUrl":"/m/hq/s/002581","defaultTab":"news","newsList":[{"id":"2531705534","title":"4月30日未名医药(002581)涨停分析:高校系、新冠防治、疫苗概念驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2531705534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531705534?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:36","pubTimestamp":1745998580,"startTime":"0","endTime":"0","summary":"证券之星消息,未名医药4月30日涨停收盘,收盘价6.61元。该股于10点5分涨停,4次打开涨停,截止收盘封单资金为468.32万元,占其流通市值0.18%。4月30日的资金流向数据方面,主力资金净流入2420.75万元,占总成交额8.97%,游资资金净流出97.12万元,占总成交额0.36%,散户资金净流出2323.63万元,占总成交额8.61%。近5日资金流向一览见下表:该股为眼科,高校系,新冠疫苗概念热股,当日眼科概念上涨2.1%,高校系概念上涨2.09%,新冠疫苗概念上涨0.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000026955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159646","BK0046","002581","BK0239","BK0197","BK0042"],"gpt_icon":0},{"id":"2531474072","title":"异动快报:未名医药(002581)4月30日10点5分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2531474072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531474072?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:10","pubTimestamp":1745979044,"startTime":"0","endTime":"0","summary":"证券之星4月30日盘中消息,10点5分未名医药触及涨停板。目前价格6.61,上涨9.98%。其所属行业生物制品目前上涨。该股为高校系,眼科,新冠病毒防治概念热股,当日高校系概念上涨2.02%,眼科概念上涨1.79%,新冠病毒防治概念上涨1.18%。4月29日的资金流向数据方面,主力资金净流出855.58万元,占总成交额47.25%,游资资金净流入236.25万元,占总成交额13.05%,散户资金净流入619.33万元,占总成交额34.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000015448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0197","BK0239","BK0046","BK0077","002581"],"gpt_icon":0},{"id":"2531604714","title":"未名医药(002581)2025年一季报简析:净利润减33.01%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2531604714","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531604714?lang=zh_cn&edition=full","pubTime":"2025-04-30 06:58","pubTimestamp":1745967515,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期未名医药发布2025年一季报。截至本报告期末,公司营业总收入3532.99万元,同比下降57.84%,归母净利润-3685.04万元,同比下降33.01%。本报告期未名医药三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达92.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000008730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581"],"gpt_icon":0},{"id":"2531201769","title":"未名医药4月29日现2笔大宗交易 成交金额913.52万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531201769","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531201769?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:40","pubTimestamp":1745919600,"startTime":"0","endTime":"0","summary":" 4月29日,未名医药(维权)收跌10.03%,收盘价为6.01元,发生2笔大宗交易,合计成交量152万股,成交金额913.52万元。 第2笔成交价格为6.01元,成交84.00万股,成交金额504.84万元,溢价率为0.00%,买方营业部为中信证券股份有限公司上海分公司,卖方营业部为机构专用。 进一步统计,近3个月内该股累计发生4笔大宗交易,合计成交金额为1320.43万元。该股近5个交易日累计下跌29.21%,主力资金合计净流出1703.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-04-29/doc-ineuvnxv5693325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0042","BK0077","BK0197","BK0046","002581","BK0239"],"gpt_icon":0},{"id":"2530496322","title":"A股CRO概念股盘初走低,未名医药一字跌停,双成药业、博济医药、泓博医药、昊帆生物纷纷低开。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530496322","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530496322?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:33","pubTimestamp":1745804005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002581","BK0077","002693","301393","301230","BK0197","BK0239","BK0046","BK0042","BK0229","399300","159982","300404","BK0216"],"gpt_icon":0},{"id":"2530905569","title":"六成营收产品被叫停,未名医药触发ST警报,股价火速跌停","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905569","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530905569?lang=zh_cn&edition=full","pubTime":"2025-04-25 16:14","pubTimestamp":1745568892,"startTime":"0","endTime":"0","summary":"从“现金牛”到“致命伤”","market":"us","thumbnail":"https://img3.gelonghui.com/7587f-e27d2830-55b4-4fa2-9447-0d1d00a197a7.jpg?guru_height=427&guru_width=640","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/7587f-e27d2830-55b4-4fa2-9447-0d1d00a197a7.jpg?guru_height=427&guru_width=640"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2097158","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"六成营收产品被叫停,未名医药触发ST警报,股价火速跌停","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["002581"],"gpt_icon":0},{"id":"2530102369","title":"异动快报:未名医药(002581)4月25日9点50分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2530102369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530102369?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:55","pubTimestamp":1745546125,"startTime":"0","endTime":"0","summary":"证券之星4月25日盘中消息,9点50分未名医药(002581)触及跌停板。目前价格7.42,下跌9.95%。其所属行业生物制品目前下跌。领涨股为甘李药业。该股为疫苗,新冠病毒防治,新冠疫苗概念热股。4月24日的资金流向数据方面,主力资金净流出638.3万元,占总成交额11.93%,游资资金净流入134.57万元,占总成交额2.52%,散户资金净流入503.73万元,占总成交额9.41%。近5日资金流向一览见下表:未名医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500012889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581","BK0077","BK0042","BK0046","BK0197","BK0239"],"gpt_icon":0},{"id":"2530669992","title":"未名医药(002581)2024年年报简析:亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2530669992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530669992?lang=zh_cn&edition=full","pubTime":"2025-04-25 06:13","pubTimestamp":1745532837,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期未名医药发布2024年年报。根据财报显示,未名医药亏损收窄。按单季度数据看,第四季度营业总收入4569.48万元,同比下降50.03%,第四季度归母净利润-1.52亿元,同比上升58.05%。本次财报公布的各项数据指标表现一般。经营活动产生的现金流量净额变动幅度为82.07%,原因:加大催收应收账款。筹资活动产生的现金流量净额变动幅度为96.22%,原因:归还借款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500006592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0042","BK0239","002581","BK0197"],"gpt_icon":0},{"id":"2530570849","title":"未名医药(002581.SZ)子公司天津未名如三个月内无法恢复生产 则可能触发其他风险警示情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2530570849","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530570849?lang=zh_cn&edition=full","pubTime":"2025-04-25 00:52","pubTimestamp":1745513546,"startTime":"0","endTime":"0","summary":"智通财经APP讯,未名医药 公告,公司控股子公司天津未名生物医药有限公司于2025年4月22日被天津市药品监督管理局采取暂停生产、销售风险控制措施。公司因天津未名停产导致主营业务受到严重影响。截止本公告披露之日,公司仍具有生产经营的能力,且天津未名预计停产时间不超过三个月。如天津未名三个月内无法恢复生产,则公司可能触发其他风险警示的情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0042","002581","BK0077","BK0197","BK0239"],"gpt_icon":0},{"id":"2528001095","title":"每周股票复盘:未名医药(002581)大宗交易机构净买入201.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528001095","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528001095?lang=zh_cn&edition=full","pubTime":"2025-04-19 06:19","pubTimestamp":1745014748,"startTime":"0","endTime":"0","summary":"截至2025年4月18日收盘,未名医药(002581)报收于8.38元,较上周的8.51元下跌1.53%。本周,未名医药4月15日盘中最高价报8.78元。4月18日盘中最低价报8.32元。未名医药当前最新总市值55.29亿元,在生物制品板块市值排名36/50,在两市A股市值排名2504/5146。本周关注点交易信息汇总: 4月16日未名医药现1笔大宗交易,机构净买入201.82万元交易信息汇总4月16日未名医药出现一笔大宗交易,机构净买入金额为201.82万元。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041900007757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0042","BK0046","BK0077","BK0239","002581"],"gpt_icon":0},{"id":"2527268789","title":"4月16日未名医药现1笔大宗交易 机构净买入201.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527268789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527268789?lang=zh_cn&edition=full","pubTime":"2025-04-16 16:53","pubTimestamp":1744793630,"startTime":"0","endTime":"0","summary":"证券之星消息,4月16日未名医药发生大宗交易,交易数据如下:大宗交易成交价格8.48元,成交23.8万股,成交金额201.82万元,买方营业部为机构专用,卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生2笔大宗交易,合计成交4790.0手。该股近期无解禁股上市。截至2025年4月16日收盘,未名医药(002581)报收于8.48元,下跌2.42%,换手率1.21%,成交量4.84万手,成交额4107.73万元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041600025935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002581","BK0042","BK0197","BK0239","BK0046"],"gpt_icon":0},{"id":"2526628911","title":"每周股票复盘:未名医药(002581)大宗交易机构净买入205.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526628911","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526628911?lang=zh_cn&edition=full","pubTime":"2025-04-12 06:32","pubTimestamp":1744410751,"startTime":"0","endTime":"0","summary":"截至2025年4月11日收盘,未名医药报收于8.51元,较上周的9.19元下跌7.4%。本周,未名医药4月7日盘中最高价报8.8元。4月9日盘中最低价报7.6元,股价触及近一年最低点。本周无涨停收盘情况,共计1次跌停收盘。未名医药当前最新总市值56.14亿元,在生物制品板块市值排名36/50,在两市A股市值排名2455/5143。本周关注点交易信息汇总: 4月11日未名医药现1笔大宗交易,机构净买入205.09万元交易信息汇总4月11日未名医药现1笔大宗交易,机构净买入205.09万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041200008419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581","BK0197","BK0077","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2516058575","title":"3月3日未名医药涨停分析:眼科,创新药,新冠病毒防治概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2516058575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516058575?lang=zh_cn&edition=full","pubTime":"2025-03-03 15:21","pubTimestamp":1740986512,"startTime":"0","endTime":"0","summary":"证券之星消息,未名医药3月3日涨停收盘,收盘价10.42元。该股于9点47分涨停,1次打开涨停,截止收盘封单资金为3311.62万元,占其流通市值0.79%。3月3日的资金流向数据方面,主力资金净流入5212.48万元,占总成交额36.8%,游资资金净流出2600.59万元,占总成交额18.36%,散户资金净流出2611.89万元,占总成交额18.44%。近5日资金流向一览见下表:该股为眼科,创新药,新冠病毒防治概念热股,当日眼科概念上涨1.61%,创新药概念上涨1.08%,新冠病毒防治概念上涨1.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300014217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK1161","BK1574","06978","002581","159992","BK0077","BK0239","BK0197"],"gpt_icon":0},{"id":"2516522564","title":"异动快报:未名医药(002581)3月3日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2516522564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516522564?lang=zh_cn&edition=full","pubTime":"2025-03-03 09:50","pubTimestamp":1740966636,"startTime":"0","endTime":"0","summary":"证券之星3月3日盘中消息,9点49分未名医药触及涨停板。目前价格10.42,上涨10.03%。其所属行业生物制品目前上涨。该股为医药,创新药,疫苗概念热股,当日医药概念上涨1.09%,创新药概念上涨1.07%,疫苗概念上涨1.0%。2月28日的资金流向数据方面,主力资金净流出1666.0万元,占总成交额19.3%,游资资金净流入770.85万元,占总成交额8.93%,散户资金净流入895.14万元,占总成交额10.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300004398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0197","BK0042","BK0239","002581","BK0046"],"gpt_icon":0},{"id":"2512450855","title":"未名医药(002581)2月19日主力资金净卖出1634.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512450855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512450855?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:24","pubTimestamp":1740014652,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年2月19日收盘,未名医药报收于10.2元,下跌0.29%,换手率1.58%,成交量6.34万手,成交额6463.94万元。2月19日的资金流向数据方面,主力资金净流出1634.74万元,占总成交额25.29%,游资资金净流入679.64万元,占总成交额10.51%,散户资金净流入955.1万元,占总成交额14.78%。融券方面,融券卖出300.0股,融券偿还5400.0股,融券余量6100.0股,融券余额6.22万元。未名医药主营业务:医药制造及CDMO生物医药代研发、代生产服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000008014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002581","BK0197","BK0046","BK0042","BK0077"],"gpt_icon":0},{"id":"2505080869","title":"未名医药(002581.SZ)发预亏,预计2024年度净亏损0.95亿元至1.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505080869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505080869?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:58","pubTimestamp":1737730694,"startTime":"0","endTime":"0","summary":"智通财经APP讯,未名医药(002581.SZ)发布2024年度业绩预告,预计全年归属于上市公司股东净亏损0.95亿元至1.55亿元。报告期内公司业绩亏损主要受以下因素影响:公司积极开展各项营销和市场探索工作,并着力于拓展新产品布局。受外部环境及行业政策等因素影响,公司主营业务收入有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002581","BK0197","BK0239","BK0077","BK0042","BK0046"],"gpt_icon":0},{"id":"2505567628","title":"未名医药:预计2024年全年每股收益亏损:0.144元至0.2349元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505567628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505567628?lang=zh_cn&edition=full","pubTime":"2025-01-24 20:03","pubTimestamp":1737720206,"startTime":"0","endTime":"0","summary":"证券之星消息,未名医药发布业绩预告,预计2024年全年每股收益亏损:0.144元至0.2349元。未名医药2024年三季报显示,公司主营收入3.15亿元,同比下降6.99%;归母净利润1462.63万元,同比下降50.78%;扣非净利润1657.06万元,同比下降49.02%;其中2024年第三季度,公司单季度主营收入1.04亿元,同比下降19.55%;单季度归母净利润4424.12万元,同比下降47.0%;单季度扣非净利润4356.39万元,同比下降45.98%;负债率3.96%,投资收益5896.22万元,财务费用-150.79万元,毛利率80.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400047913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002581","BK0042","BK0239","BK0046","BK0197","BK0077"],"gpt_icon":0},{"id":"2505092127","title":"【未名医药:签署6463万元工程总承包合同】未名医药公告,公司全资子公司山东衍渡生物科技有限公司将与山东中大工程科技有限公司淄博分公司签署《建设项目工程总承包合同》。合同涉及山东未名生物医药产业园项目的洁净车间及机电总包工程,合同总金额为6463万元,预计工期为180天,计划于2025年2月10日开始施工,并于2025年8月9日完工。合同的执行将有助于公司提高产能规模和市场份额,进一步完善产业布局,增强综合竞争力。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505092127","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505092127?lang=zh_cn&edition=full","pubTime":"2025-01-23 20:21","pubTimestamp":1737634864,"startTime":"0","endTime":"0","summary":"未名医药公告,公司全资子公司山东衍渡生物科技有限公司将与山东中大工程科技有限公司淄博分公司签署《建设项目工程总承包合同》。合同涉及山东未名生物医药产业园项目的洁净车间及机电总包工程,合同总金额为6463万元,预计工期为180天,计划于2025年2月10日开始施工,并于2025年8月9日完工。合同的执行将有助于公司提高产能规模和市场份额,进一步完善产业布局,增强综合竞争力。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/23202147759985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161726","002581","399441","BK0197","BK0042","BK0239","159837","BK0046","BK0077"],"gpt_icon":0},{"id":"2504532907","title":"未名医药上涨5.13%,报10.86元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2504532907","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504532907?lang=zh_cn&edition=full","pubTime":"2025-01-17 13:33","pubTimestamp":1737091993,"startTime":"0","endTime":"0","summary":"1月17日,未名医药盘中上涨5.13%,截至13:33,报10.86元/股,成交5799.16万元,换手率1.37%,总市值71.65亿元。截至9月30日,未名医药股东户数3.42万,人均流通股1.17万股。2024年1月-9月,未名医药实现营业收入3.15亿元,同比减少6.99%;归属净利润1462.63万元,同比减少50.78%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/17133347545178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002581","BK0197","BK0046","BK0042","BK0077"],"gpt_icon":0},{"id":"2501710008","title":"未名医药收盘下跌2.59%,最新市净率3.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2501710008","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501710008?lang=zh_cn&edition=full","pubTime":"2025-01-08 16:56","pubTimestamp":1736326616,"startTime":"0","endTime":"0","summary":"1月8日,未名医药今日收盘10.9元,下跌2.59%,最新市净率3.44。股东方面,截至2024年9月30日,未名医药股东户数34233户,较上次增加235户,户均持股市值35.28万元,户均持股数量2.76万股。山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。最新一期业绩显示,2024年三季报,公司实现营业收入3.15亿元,同比-6.99%;净利润1462.63万元,同比-50.78%,销售毛利率80.24%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/08165647255540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002581","BK0042","BK0077","BK0046","BK0197"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746475386981,"stockEarnings":[{"period":"1week","weight":-0.2178},{"period":"1month","weight":-0.299},{"period":"3month","weight":-0.3397},{"period":"6month","weight":-0.4665},{"period":"1year","weight":-0.521},{"period":"ytd","weight":-0.3788}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东未名生物医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38037人(较上一季度增加13.35%)","perCapita":"10536股","listingDate":"2011-05-20","address":"山东省淄博市张店区淄博科技工业园南支一路(兴园路)28号","registeredCapital":"65973万元","survey":" 山东未名生物医药股份有限公司主营业务为为干扰素、神经生长因子、生物医药CRO/CDMO、疫苗和医药中间体等五大生物医药板块。主要产品有鼠神经生长因子、干扰素、技术服务。公司子公司天津未名是我国率先进入基因工程制药产业化领域的企业之一。重点发展人干扰素α2b系列产品,主要产品捷抚-重组人干扰素α2b喷雾剂(假单胞菌),是全球第一支干扰素喷雾剂。","listedPrice":19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"未名医药,002581,未名医药股票,未名医药股票老虎,未名医药股票老虎国际,未名医药行情,未名医药股票行情,未名医药股价,未名医药股市,未名医药股票价格,未名医药股票交易,未名医药股票购买,未名医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"未名医药(002581)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供未名医药(002581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}